Annual FCF
-$4.06B$230.00M-6.01%
Summary
- Current Value
- As of today, MRNA annual free cash flow is -$4.06B, down -6.01% on
- Historical Performance
- MRNA annual free cash flow is down -130.41% over the past 3 years, and down -725.87% over the past 5 years
- All-Time High Comparison
- MRNA annual free cash flow is currently -130.41% below its historical high of $13.34B set on
- 3-Year Low Comparison
- MRNA annual free cash flow is at its 3-year low
- Sector Comparison
- MRNA annual free cash flow is higher than 0.08% of companies in Healthcare sector
Free Cash Flow Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Free Cash Flow | -$4.06B | -6.0% | -130.4% | -725.9% | -10000.0% | |
| Quarterly Free Cash Flow | -$880.00M | +48.8% | -639.9% | -200.8% | -10000.0% | |
| TTM Free Cash Flow | -$2.66B | +32.7% | -142.9% | -533.8% | -10000.0% | |
| Price | $33.84 | -19.9% | -82.0% | -72.8% | – | |
| Annual Cash From Operations | -$3.00B | +3.7% | -122.1% | -554.5% | -10000.0% | |
| Annual CAPEX | $1.05B | +48.7% | +270.1% | +3230.8% | +10000.0% | |
| Annual Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | – | |
| Annual Net Income | -$3.56B | +24.5% | -129.2% | -592.8% | -10000.0% | |
| Annual Revenue | $3.24B | -52.7% | -82.4% | +5274.6% | +10000.0% |
Free Cash Flow Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $4.58B | N/A | -188.5% |
| 5Y | $13.34B | -130.4% | |
| All | $13.34B | -130.4% |
Free Cash Flow Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$4.06B | at low | |
| 5Y | -$4.06B | at low | |
| All | -$4.06B | at low |
Free Cash Flow History
FAQ
What is the current annual free cash flow of MRNA?
As of today, MRNA annual free cash flow is -$4.06B
What is 1-year change in MRNA annual free cash flow?
MRNA annual free cash flow is down -6.01% year-over-year
What is 3-year change in MRNA annual free cash flow?
MRNA annual free cash flow is down -130.41% over the past 3 years
How far is MRNA annual free cash flow from its all-time high?
MRNA annual free cash flow is currently -130.41% below its historical high of $13.34B set on December 31, 2021
How does MRNA annual free cash flow rank versus sector peers?
MRNA annual free cash flow is higher than 0.08% of companies in Healthcare sector
When is MRNA next annual earnings release?
The next annual earnings release for MRNA is on
Quarterly FCF
-$880.00M$42.00M+4.56%
Summary
- Current Value
- As of today, MRNA quarterly free cash flow is -$880.00M, up +4.56% on
- Historical Performance
- MRNA quarterly free cash flow is up +48.75% year-over-year, and down -639.88% over the past 3 years
- All-Time High Comparison
- MRNA quarterly free cash flow is currently -121.82% below its historical high of $4.03B set on
- 3-Year Low Comparison
- MRNA quarterly free cash flow is +49.43% above its 3-year low of -$1.74B reached on
- Sector Comparison
- MRNA quarterly free cash flow is higher than 0.18% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Free Cash Flow | -$880.00M | +4.6% | +48.8% | -639.9% | -200.8% | |
| Annual Free Cash Flow | -$4.06B | – | -6.0% | -130.4% | -725.9% | |
| TTM Free Cash Flow | -$2.66B | +23.9% | +32.7% | -142.9% | -533.8% | |
| Price | $33.84 | +26.1% | -19.9% | -82.0% | -72.8% | |
| Quarterly Cash From Operations | -$847.00M | +7.8% | +45.9% | -436.1% | -194.9% | |
| Quarterly CAPEX | $33.00M | +1000.0% | -78.2% | -62.9% | +71.1% | |
| Quarterly Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Net Income | -$200.00M | +75.8% | -1638.5% | -119.2% | +14.4% | |
| Quarterly Revenue | $1.02B | +615.5% | -45.4% | -69.3% | +543.4% |
Quarterly Free Cash Flow Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $303.00M | N/A | -390.4% |
| 3Y | $1.57B | N/A | -156.1% |
| 5Y | $4.03B | -121.8% | |
| All | $4.03B | -121.8% |
Quarterly Free Cash Flow Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$1.16B | +24.4% | |
| 3Y | -$1.74B | +49.4% | |
| 5Y | -$1.74B | +49.4% | |
| All | -$1.74B | +49.4% |
Quarterly Free Cash Flow History
FAQ
What is the current quarterly free cash flow of MRNA?
As of today, MRNA quarterly free cash flow is -$880.00M
What is MRNA quarterly free cash flow most recent change?
MRNA quarterly free cash flow was up +4.56% on September 30, 2025
What is 1-year change in MRNA quarterly free cash flow?
MRNA quarterly free cash flow is up +48.75% year-over-year
How far is MRNA quarterly free cash flow from its all-time high?
MRNA quarterly free cash flow is currently -121.82% below its historical high of $4.03B set on June 30, 2021
How does MRNA quarterly free cash flow rank versus sector peers?
MRNA quarterly free cash flow is higher than 0.18% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
TTM FCF
-$2.66B$837.00M+23.91%
Summary
- Current Value
- As of today, MRNA TTM free cash flow is -$2.66B, up +23.91% on
- Historical Performance
- MRNA TTM free cash flow is up +32.68% year-over-year, and down -142.94% over the past 3 years
- All-Time High Comparison
- MRNA TTM free cash flow is currently -119.97% below its historical high of $13.34B set on
- 3-Year Low Comparison
- MRNA TTM free cash flow is +34.33% above its 3-year low of -$4.06B reached on
- Sector Comparison
- MRNA TTM free cash flow is higher than 0.09% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Free Cash Flow | -$2.66B | +23.9% | +32.7% | -142.9% | -533.8% | |
| Annual Free Cash Flow | -$4.06B | – | -6.0% | -130.4% | -725.9% | |
| Quarterly Free Cash Flow | -$880.00M | +4.6% | +48.8% | -639.9% | -200.8% | |
| Price | $33.84 | +26.1% | -19.9% | -82.0% | -72.8% | |
| TTM Cash From Operations | -$1.98B | +26.7% | +38.3% | -129.8% | -397.6% | |
| TTM CAPEX | $685.00M | -14.7% | -8.5% | +60.0% | +1248.2% | |
| TTM Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| TTM Net Income | -$3.12B | -7.3% | -40.1% | -126.5% | -420.4% | |
| TTM Revenue | $2.23B | -27.5% | -56.0% | -89.5% | +804.7% |
TTM Free Cash Flow Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$2.66B | at high | |
| 3Y | $4.58B | N/A | -158.1% |
| 5Y | $13.34B | -120.0% | |
| All | $13.34B | -120.0% |
TTM Free Cash Flow Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$4.06B | N/A | +34.3% |
| 3Y | -$4.06B | +34.3% | |
| 5Y | -$4.06B | +34.3% | |
| All | -$4.06B | +34.3% |
TTM Free Cash Flow History
FAQ
What is the current TTM free cash flow of MRNA?
As of today, MRNA TTM free cash flow is -$2.66B
What is MRNA TTM free cash flow most recent change?
MRNA TTM free cash flow was up +23.91% on September 30, 2025
What is 1-year change in MRNA TTM free cash flow?
MRNA TTM free cash flow is up +32.68% year-over-year
How far is MRNA TTM free cash flow from its all-time high?
MRNA TTM free cash flow is currently -119.97% below its historical high of $13.34B set on December 31, 2021
How does MRNA TTM free cash flow rank versus sector peers?
MRNA TTM free cash flow is higher than 0.09% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
Free Cash Flow Formula
FCF = − CAPEX
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1682852/000168285225000075/0001682852-25-000075-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000168285225000022/0001682852-25-000022-index.htm
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna